Frontlight ResearchEarly access
Trial site
Institute of Rheumatology
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)6 trials
- Dermatomyositis and polymyositis (myositis)3 trials
- Rheumatoid arthritis2 trials
- Fibromyalgia1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Enrolling by invitation2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Biogen3 trials
- argenx2 trials
- Janssen Research & Development, LLC2 trials
- Alfasigma S.p.A.1 trial
- Boehringer Ingelheim1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Recruiting
Enrolling by invitation
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Lupus (SLE)2 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026